A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2021; you can also visit the original URL.
The file type is
We mined published microarray data (1) to understand the most significant gene expression differences in the tumors of triple negative breast cancer patients based on survival following treatment: dead or alive. We observed significant transcriptome-wide differential expression of serpin peptidase inhibitor, clade B (ovalbumin), member 9, encoded by SERPINB9 when comparing the primary tumors of triple negative breast cancer patients dead or alive. Importantly, SERPINB9 expression was correlateddoi:10.31219/osf.io/4hrtd fatcat:s6i3klh57zaz3ivnawtxuku5uq